Navigation Links
Governor O'Malley Announces State Grants Available For Maryland Bio Companies
Date:8/24/2010

BALTIMORE, Aug. 24 /PRNewswire-USNewswire/ -- Governor Martin O'Malley announced today that State grants are available in Fiscal Year 2011 through the Maryland Biotechnology Center to assist in commercializing promising research, encouraging bio companies to collaborate with academic institutions and expanding biotechnology resources.  The Governor also announced that seven Maryland bio companies and universities received $1.3 million in FY 2010 grants, which was the first year of funding.

"Biotechnology continues to be a key driver of Maryland's economy," said Governor O'Malley. "The high quality of the biotechnology projects supported by these awards, as well as their link to a number of Maryland institutions of higher learning, demonstrates Maryland's significant potential to commercialize our unparalleled academic research."

Applications for the Biotechnology Commercialization Awards and the Translational Research Awards must be submitted by September 15th to the Maryland Biotechnology Center (MBC), a part of the Maryland Department of Business and Economic Development (DBED), at www.marylandbiocenter.org.  These grants complement funding available through TEDCO's Maryland Technology Transfer and Commercialization Fund, the University of Maryland's Maryland Industrial Partnerships Program and DBED's Maryland Venture Fund programs.

In Fiscal Year 2010, the Biotechnology Commercialization Awards were made to three biotechnology companies to assist them in commercializing a product or service.  College Park-based Zymetis, received a $200,000 grant to advance their work in converting whey to fuel; Fyodor, based in Baltimore's BioPark, received $200,000 for the commercialization of their flagship product, the Urine Malaria Test; and InfraTrac, located at the Silver Spring Innovation Center, received $100,000 to grow their counterfeit drug monitoring product.

The Translational Research Awards, which are given to help commercialize basic science research and encourage bio companies to collaborate with academic institutions, were presented to Baltimore-based Gliknik Inc., in partnership with the University of Maryland, Baltimore and Dr. James S. Gammie of the University of Maryland Medical Center.  Each has received a $200,000 award. Gliknik will use its award to support development of a drug that aids in organ transplants, with a significant portion of the funding going to transplant researchers at the University of Maryland. Dr. Gammie will use the funding to develop surgical tools that will assist in repairing the heart's mitral valve through a minimally invasive procedure.

The Shared Resource Grants, totaling $400,000, were awarded to two University of Maryland programs that provide specialized services to local bio companies. The Maryland Technology Enterprise Institute (MTECH) Biotechnology Research and Education program received $200,000 to expand its operations into a new facility at Shady Grove.  A second $200,000 grant was awarded to the Department of Chemistry and Biochemistry at the University of Maryland, Baltimore County for the purchase of new equipment, specifically a state-of-the-art mass spectrometer.  


'/>"/>
SOURCE Maryland Department of Business and Economic Development
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Howard J. Leonhardt Announces Candidacy for Governor of California
2. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
3. Venture Capitalists to Invest in Promising PA Life Science Companies, Governor Rendell Says
4. The Biotechnology Industry Organization Honors Georgia Governor Sonny Perdue as Governor of the Year
5. Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come
6. Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
7. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
8. 3SBio Inc. Announces Unaudited Second Quarter Results
9. SeqWright Announces the Addition of Illumina HiSeq 2000 to its Next Generation Sequencing Capabilities
10. Spherix Announces Second Quarter 2010 Financial Results
11. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):